ReviewPharmacoEconomics2013
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisal.
Jonathan Tosh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it